Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Genentech, Inc.

Latest From Genentech, Inc.

Roche’s Susvimo Returns, But Destined To Be Vabysmo’s Support Act

The implantable eye treatment will be back on the market soon, but risk of eye infections and complications remain higher than with injectable treatments, meaning it will play second fiddle to Vabysmo.

Approvals Ophthalmic

Stock Watch: Biotechs Sell The Family Silver

When loss-making biotech companies mix debt with sluggish sales, difficult options like restructuring and asset sales remain.

Stock Watch M & A

PRISM BioLab Completes Successful Tokyo IPO On Back Of Multiple Partnerships

The Japanese drug discovery bioventure builds on multiple alliances and an in-house platform to get away a successful IPO in Tokyo, which it will use to fund further pipeline and technology development.

Japan Commercial

VC Investment Surges In Q2 As Financial Market Recovery Momentum Builds

Even after removing Xaira’s unusual $1bn seed financing, Evaluate’s data show that biopharma venture capital fundraising increased from the first to the second quarter and from Q2 of last year.

Financing Evaluate Data
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Biotechnology
    • Large Molecule
      • Antibodies
  • Other Names / Subsidiaries
    • Tanox